Mr Spencer C. Joffrion > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Mr Spencer C. Joffrion
Work Department
Intellectual Property
Career
Spencer C. Joffrion practices in the areas of intellectual property and corporate law, with a focus on the pharmaceutical, media, and technology industries. He has significant experience assisting both global and U.S.-based clients with large-scale, international projects related to complex M&A, leveraged finance and corporate governance. Mr. Joffrion also represents public and private companies in relation to U.S. securities law compliance, secured and unsecured financing transactions, corporate governance, and due diligence reviews.
Education
- New York University, B.S., Philosophy, 2008
- New York University School of Law, J.D., 2015, Editor-in-Chief of the New York University Journal of Intellectual Property & Entertainment Law
Top Tier Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation